IOMICS Corporation
IOMICS is an AI company focused on accelerating drug discovery, drug repurposing, and polypharmacology through its Agentic AI platform. Their core product, The Cures Accelerator™, leverages AI, machine learning, bioinformatics, computational chemistry, and network sciences with billions of data points to enable smarter, context-driven research. The platform supports various aspects of drug development from identifying clinical phenotypes and molecular biomarkers to optimizing chemical compounds for ADMET properties. IOMICS aims to provide a demonstrable business advantage to its life science clients and partners by improving decision-making in the lab and clinic, and advancing precision medicine.
IOMICS Corporation
IOMICS is an AI company focused on accelerating drug discovery, drug repurposing, and polypharmacology through its Agentic AI platform. Their core product, The Cures Accelerator™, leverages AI, machine learning, bioinformatics, computational chemistry, and network sciences with billions of data points to enable smarter, context-driven research. The platform supports various aspects of drug development from identifying clinical phenotypes and molecular biomarkers to optimizing chemical compounds for ADMET properties. IOMICS aims to provide a demonstrable business advantage to its life science clients and partners by improving decision-making in the lab and clinic, and advancing precision medicine.